Inventiva S.A. Sponsored ADR

IVA Healthcare Biotechnology

Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.

2.94 0.17 −5.47%
Market cap
$740.0M
P/E
0.0×
Fwd P/E
−4.6×
Dividend yield
—
F-score
4/9
Altman Z
−1.36
Beneish M
−7.91
Dividend safety
n/a
Jun '26 Jun '25 Jun '24 Jun '23 Older periods
ROE
0.00% 0.00% 0.00% (299.62%)

+8 more TTM periods

ROA
0.00% 0.00% 0.00% (134.83%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
0.00% 0.00% 0.00% (611.61%)
Average Days of Receivables
0.00 0.00 0.00 134.41
Free Cash Flow per Share
— 0.00 0.00 0.00
Free Cash Flow
— (137.54) (105.47) (128.69)
Capital Expenditures
— (0.64) (0.65) (0.52)
Other line items
Cash ROIC
0.00% (71.14%) 599.34% (201.04%)
Accounts Receivable Turnover
0.00 0.00 0.00 3.65
Accounts Payable Turnover
0.00 0.00 0.00 0.00
Inventory Turnover
— — 0.00 0.00
Average Days of Payables
0.00 0.00 0.00 0.00
Days of Inventory on Hand
— — 0.00 0.00
Tax Rate
— — — (0.08)
Research and Development Expense of Revenue
— — — 777.68%
Selling, General and Administrative Expense of Revenue
— — — 152.29%
Share Based Compensation of Revenue
— 0.00% 0.00% 0.00%
Interest Coverage
— — — 0.00
Operating CF/Net income
— 0.00 0.00 0.87
Depreciation/Fixed assets
0.00 1.62 0.49 0.42
Capex/Depreciation
— (0.09) (0.16) (0.15)
Revenue per Share
— — — 0.00
Operating CF per Share
— 0.00 0.00 0.00
Capex per Share
— 0.00 0.00 0.00
Capex to Sales
— 0.00 0.00 0.03

Fold the line items

Columns are period end dates · fundamentals updated 30 Sep 2026